282 related articles for article (PubMed ID: 35714307)
21. The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia.
Nakauchi Y; Azizi A; Thomas D; Corces MR; Reinisch A; Sharma R; Cruz Hernandez D; Köhnke T; Karigane D; Fan A; Martinez-Krams D; Stafford M; Kaur S; Dutta R; Phan P; Ediriwickrema A; McCarthy E; Ning Y; Phillips T; Ellison CK; Guler GD; Bergamaschi A; Ku CJ; Levy S; Majeti R
Blood Cancer Discov; 2022 Jul; 3(4):346-367. PubMed ID: 35532363
[TBL] [Abstract][Full Text] [Related]
22. Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.
Imi T; Katagiri T; Hosomichi K; Zaimoku Y; Hoang Nguyen V; Nakagawa N; Tajima A; Yoshizato T; Ogawa S; Nakao S
Blood Adv; 2018 May; 2(9):1000-1012. PubMed ID: 29720492
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction.
Wang S; Hu S; Luo X; Bao X; Li J; Liu M; Lv Y; Zhao C; Zeng M; Chen X; Unsworth A; Jones S; Johnson TW; White SJ; Jia H; Yu B
EBioMedicine; 2022 Apr; 78():103964. PubMed ID: 35339897
[TBL] [Abstract][Full Text] [Related]
24. Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.
Joshi K; Zhang L; Breslin S J P; Kini AR; Zhang J
J Exp Clin Cancer Res; 2022 Oct; 41(1):294. PubMed ID: 36203205
[TBL] [Abstract][Full Text] [Related]
25. Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction.
Wang Y; Sano S; Yura Y; Ke Z; Sano M; Oshima K; Ogawa H; Horitani K; Min KD; Miura-Yura E; Kour A; Evans MA; Zuriaga MA; Hirschi KK; Fuster JJ; Pietras EM; Walsh K
JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32154790
[TBL] [Abstract][Full Text] [Related]
26. Shared and distinct genetic etiologies for different types of clonal hematopoiesis.
Brown DW; Cato LD; Zhao Y; Nandakumar SK; Bao EL; Gardner EJ; Hubbard AK; DePaulis A; Rehling T; Song L; Yu K; Chanock SJ; Perry JRB; Sankaran VG; Machiela MJ
Nat Commun; 2023 Sep; 14(1):5536. PubMed ID: 37684235
[TBL] [Abstract][Full Text] [Related]
27. TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity.
Fuster JJ; Zuriaga MA; Zorita V; MacLauchlan S; Polackal MN; Viana-Huete V; Ferrer-Pérez A; Matesanz N; Herrero-Cervera A; Sano S; Cooper MA; González-Navarro H; Walsh K
Cell Rep; 2020 Oct; 33(4):108326. PubMed ID: 33113366
[TBL] [Abstract][Full Text] [Related]
28. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
29. Clonal haematopoiesis of emerging significance.
Hammond D; Loghavi S
Pathology; 2021 Apr; 53(3):300-311. PubMed ID: 33685721
[TBL] [Abstract][Full Text] [Related]
30. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
Cobo I; Tanaka T; Glass CK; Yeang C
Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years.
van Zeventer IA; Salzbrunn JB; de Graaf AO; van der Reijden BA; Boezen HM; Vonk JM; van der Harst P; Schuringa JJ; Jansen JH; Huls G
Blood Adv; 2021 Apr; 5(8):2115-2122. PubMed ID: 33877299
[TBL] [Abstract][Full Text] [Related]
32. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
[TBL] [Abstract][Full Text] [Related]
33. Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations.
Mangaonkar AA; Patnaik MM
Am J Hematol; 2023 Jun; 98(6):951-964. PubMed ID: 36938794
[TBL] [Abstract][Full Text] [Related]
34. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
[TBL] [Abstract][Full Text] [Related]
35. Causes and consequences of clonal hematopoiesis.
Weeks LD; Ebert BL
Blood; 2023 Dec; 142(26):2235-2246. PubMed ID: 37931207
[TBL] [Abstract][Full Text] [Related]
36. Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma.
Meier J; Jensen JL; Dittus C; Coombs CC; Rubinstein S
Blood Rev; 2022 Nov; 56():100986. PubMed ID: 35753868
[TBL] [Abstract][Full Text] [Related]
37. STING activation in TET2-mutated hematopoietic stem/progenitor cells contributes to the increased self-renewal and neoplastic transformation.
Xie J; Sheng M; Rong S; Zhou D; Wang C; Wu W; Huang J; Sun Y; Wang Y; Chen P; Wu Y; Wang Y; Wang L; Zhou BO; Huang X; Walsh CP; Bohlander SK; Huang J; Wang X; Xu GL; Gao H; Shi Y
Leukemia; 2023 Dec; 37(12):2457-2467. PubMed ID: 37816954
[TBL] [Abstract][Full Text] [Related]
38. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
[TBL] [Abstract][Full Text] [Related]
39. Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications.
Nathan DI; Dougherty M; Bhatta M; Mascarenhas J; Marcellino BK
Crit Rev Oncol Hematol; 2023 Dec; 192():104187. PubMed ID: 37879493
[TBL] [Abstract][Full Text] [Related]
40. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia.
Tothova Z; Krill-Burger JM; Popova KD; Landers CC; Sievers QL; Yudovich D; Belizaire R; Aster JC; Morgan EA; Tsherniak A; Ebert BL
Cell Stem Cell; 2017 Oct; 21(4):547-555.e8. PubMed ID: 28985529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
